139 related articles for article (PubMed ID: 1689771)
1. Human monoclonal IgM anti-Gal(beta 1-3)GalNAc autoantibodies bind to the surface of bovine spinal motoneurons.
Thomas FP; Thomas JE; Sadiq SA; van den Berg LH; Roelofs RI; Latov N; Hays AP
J Neuropathol Exp Neurol; 1990 Mar; 49(2):89-95. PubMed ID: 1689771
[TBL] [Abstract][Full Text] [Related]
2. Identification of glycoconjugates which are targets for anti-Gal(beta 1-3)GalNAc autoantibodies in spinal motor neurons.
Lugaresi A; Corbo M; Thomas FP; Miyatani N; Ariga T; Yu RK; Hays AP; Latov N
J Neuroimmunol; 1991 Oct; 34(1):69-76. PubMed ID: 1716641
[TBL] [Abstract][Full Text] [Related]
3. Lower motor neuron disease in a patient with autoantibodies against Gal(beta 1-3)GalNAc in gangliosides GM1 and GD1b: improvement following immunotherapy.
Shy ME; Heiman-Patterson T; Parry GJ; Tahmoush A; Evans VA; Schick PK
Neurology; 1990 May; 40(5):842-4. PubMed ID: 2330115
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal IgMs with anti-Gal(beta 1-3) GalNAc activity in lower motor neuron disease; identification of glycoprotein antigens in neural tissue and cross-reactivity with serum immunoglobulins.
Thomas FP; Lee AM; Romas SN; Latov N
J Neuroimmunol; 1989 Jul; 23(2):167-74. PubMed ID: 2470785
[TBL] [Abstract][Full Text] [Related]
5. Motor neuron syndrome and monoclonal IgM with antibody activity against gangliosides GM1 and GD1b.
Nardelli E; Steck AJ; Barkas T; Schluep M; Jerusalem F
Ann Neurol; 1988 May; 23(5):524-8. PubMed ID: 3389760
[TBL] [Abstract][Full Text] [Related]
6. Antibodies to glycoconjugates in human motor neuron disease.
Latov N; Hays AP; Yu RK; Ito H; Thomas FP
Neurochem Pathol; 1988 Jun; 8(3):181-7. PubMed ID: 3253621
[TBL] [Abstract][Full Text] [Related]
7. Isolated bovine spinal motoneurons have specific ganglioside antigens recognized by sera from patients with motor neuron disease and motor neuropathy.
Yoshino H; Miyatani N; Saito M; Ariga T; Lugaresi A; Latov N; Kushi Y; Kasama T; Yu RK
J Neurochem; 1992 Nov; 59(5):1684-91. PubMed ID: 1383424
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal IgM in two patients with motor neuron disease bind to the carbohydrate antigens Gal(beta 1-3)GalNAc and Gal(beta 1-3)GlcNAc.
Ito H; Latov N
J Neuroimmunol; 1988 Sep; 19(3):245-53. PubMed ID: 2457603
[TBL] [Abstract][Full Text] [Related]
9. Human monoclonal IgM with autoantibody activity against two gangliosides (GM1 and GD1b) in a patient with motor neuron syndrome.
Jauberteau MO; Gualde N; Preud'Homme JL; Rigaud M; Gil R; Vallat JM; Baumann N
Clin Exp Immunol; 1990 May; 80(2):186-91. PubMed ID: 2357844
[TBL] [Abstract][Full Text] [Related]
10. Gangliosides GM1 and GD1b are antigens for IgM M-protein in a patient with motor neuron disease.
Freddo L; Yu RK; Latov N; Donofrio PD; Hays AP; Greenberg HS; Albers JW; Allessi AG; Keren D
Neurology; 1986 Apr; 36(4):454-8. PubMed ID: 3960319
[TBL] [Abstract][Full Text] [Related]
11. Identification of gangliosides recognized by IgG anti-GalNAc-GD1a antibodies in bovine spinal motor neurons and motor nerves.
Yoshino H; Ariga T; Suzuki A; Yu RK; Miyatake T
Brain Res; 2008 Aug; 1227():216-20. PubMed ID: 18598683
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal IgM with unique specificity to gangliosides GM1 and GD1b and to lacto-N-tetraose associated with human motor neuron disease.
Latov N; Hays AP; Donofrio PD; Liao J; Ito H; McGinnis S; Konstadoulakis M; Freddo L; Shy ME
Neurology; 1988 May; 38(5):763-8. PubMed ID: 2452383
[TBL] [Abstract][Full Text] [Related]
13. Localization of neural epitopes that bind to IgM monoclonal autoantibodies (M-proteins) from two patients with motor neuron disease.
Thomas FP; Adapon PH; Goldberg GP; Latov N; Hays AP
J Neuroimmunol; 1989 Jan; 21(1):31-9. PubMed ID: 2461959
[TBL] [Abstract][Full Text] [Related]
14. Mapping immunoreactive epitopes in the human peripheral nervous system using human monoclonal anti-GM1 ganglioside antibodies.
O'Hanlon GM; Paterson GJ; Veitch J; Wilson G; Willison HJ
Acta Neuropathol; 1998 Jun; 95(6):605-16. PubMed ID: 9650753
[TBL] [Abstract][Full Text] [Related]
15. Immunostaining of motor nerve terminals by IgM M protein with activity against gangliosides GM1 and GD1b from a patient with motor neuron disease.
Schluep M; Steck AJ
Neurology; 1988 Dec; 38(12):1890-2. PubMed ID: 2461538
[TBL] [Abstract][Full Text] [Related]
16. Patterns of reactivity of human anti-GM1 antibodies with spinal cord and motor neurons.
Corbo M; Quattrini A; Lugaresi A; Santoro M; Latov N; Hays AP
Ann Neurol; 1992 Oct; 32(4):487-93. PubMed ID: 1456733
[TBL] [Abstract][Full Text] [Related]
17. Reactivity of a human monoclonal anti-GM1 and anti-GD1b IgM antibody with human neurons in cultures.
Jauberteau MO; Brindel I; Baumann N; Preud'homme JL
J Neuroimmunol; 1993 Oct; 48(1):53-7. PubMed ID: 8227308
[TBL] [Abstract][Full Text] [Related]
18. Generation of antibodies to gangliosides GM1 and GD1b. Genetic control of fine antigenic specificity.
Ito H; Yu RK; Latov N
Ann N Y Acad Sci; 1988; 540():258-60. PubMed ID: 2462804
[No Abstract] [Full Text] [Related]
19. Antibodies to GM1 and Gal(beta 1-3)GalNAc at the nodes of Ranvier in human and experimental autoimmune neuropathy.
Thomas FP
Microsc Res Tech; 1996 Aug; 34(6):536-43. PubMed ID: 8842022
[TBL] [Abstract][Full Text] [Related]
20. N-glycolylneuraminic acid-containing GM1 is a new molecule for serum antibody in Guillain-Barré syndrome.
Odaka M; Yuki N; Yoshino H; Kasama T; Handa S; Irie F; Hirabayashi Y; Suzuki A; Hirata K
Ann Neurol; 1998 Jun; 43(6):829-34. PubMed ID: 9629854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
